Menu

Filtros : "FCF-FBF" Removidos: "CIENCIAS FLORESTAIS" "SOCIOLOGIA" "FLAVONÓIDES" "Brasil" Limpar

Filtros

Refine with date range

1 - 20 (5.040 records)

  • Curadoria

    Reunião Anual da Sociedade Brasileira de Química- SBQ, 47 (2024)

    Cavalheiro, Carla Cristina Schmitt ; Lopes, Norberto Peporine ; Fornaro, Adalgiza ; Trossini, Gustavo Henrique Goulart

    Source: Anais. Conference titles: Reunião Anual da Sociedade Brasileira de Química - RASBQ. Unidades: IQSC, FCFRP, IAG, FCF

    Subjects: QUÍMICA, CONGRESSO NACIONAL

    Acesso à fonteHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      CAVALHEIRO, Carla Cristina Schmitt et al. Reunião Anual da Sociedade Brasileira de Química- SBQ, 47. Anais. São Paulo: Instituto de Química de São Carlos, Universidade de São Paulo. Disponível em: https://www.eventweb.com.br/rasbq2024/home-event/schedule.php?q=&area=todas&sessao=todas&tipo=1#trabalhos. Acesso em: 02 jul. 2024. , 2024

    • APA

      Cavalheiro, C. C. S., Lopes, N. P., Fornaro, A., & Trossini, G. H. G. (2024). Reunião Anual da Sociedade Brasileira de Química- SBQ, 47. Anais. São Paulo: Instituto de Química de São Carlos, Universidade de São Paulo. Recuperado de https://www.eventweb.com.br/rasbq2024/home-event/schedule.php?q=&area=todas&sessao=todas&tipo=1#trabalhos

    • NLM

      Cavalheiro CCS, Lopes NP, Fornaro A, Trossini GHG. Reunião Anual da Sociedade Brasileira de Química- SBQ, 47 [Internet]. Anais. 2024 ;[citado 2024 jul. 02 ] Available from: https://www.eventweb.com.br/rasbq2024/home-event/schedule.php?q=&area=todas&sessao=todas&tipo=1#trabalhos

    • Vancouver

      Cavalheiro CCS, Lopes NP, Fornaro A, Trossini GHG. Reunião Anual da Sociedade Brasileira de Química- SBQ, 47 [Internet]. Anais. 2024 ;[citado 2024 jul. 02 ] Available from: https://www.eventweb.com.br/rasbq2024/home-event/schedule.php?q=&area=todas&sessao=todas&tipo=1#trabalhos

  • Artigo de periodico-carta/editorial

    Empowering voices: inspiring women in medicinal chemistry [Editorial] (2024)

    Blanco, Maria Jesus ; Bronson, Joanne J ; DiMauro, Erin F ; Dzierba, Carolyn ; Eggen, MariJean ; Garner, Amanda L ; Georg, Gunda ; Giarolla, Jeanine ; Goodwin, Nicole C ; Davies, Melissa C. Grenier ; Luevano, Carrie Haskell ; Holzgrabe, Ulrike ; Huang, Rong ; Lagiakos, H. Rachel ; Leftheris, Katerina ; Martin, Yvonne; Matos, Maria João ; Dracka, Tricia L. May

    Source: Journal of Medicinal Chemistry. Unidade: FCF

    Subjects: MULHERES, QUÍMICA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      BLANCO, Maria Jesus et al. Empowering voices: inspiring women in medicinal chemistry [Editorial]. Journal of Medicinal Chemistry. Washington: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: https://dx.doi.org/10.1021/acsmedchemlett.4c00097. Acesso em: 02 jul. 2024. , 2024

    • APA

      Blanco, M. J., Bronson, J. J., DiMauro, E. F., Dzierba, C., Eggen, M. J., Garner, A. L., et al. (2024). Empowering voices: inspiring women in medicinal chemistry [Editorial]. Journal of Medicinal Chemistry. Washington: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. doi:10.1021/acsmedchemlett.4c00097

    • NLM

      Blanco MJ, Bronson JJ, DiMauro EF, Dzierba C, Eggen MJ, Garner AL, Georg G, Giarolla J, Goodwin NC, Davies MCG, Luevano CH, Holzgrabe U, Huang R, Lagiakos HR, Leftheris K, Martin Y, Matos MJ, Dracka TLM. Empowering voices: inspiring women in medicinal chemistry [Editorial] [Internet]. Journal of Medicinal Chemistry. 2024 ; 67 4251-4258.[citado 2024 jul. 02 ] Available from: https://dx.doi.org/10.1021/acsmedchemlett.4c00097

    • Vancouver

      Blanco MJ, Bronson JJ, DiMauro EF, Dzierba C, Eggen MJ, Garner AL, Georg G, Giarolla J, Goodwin NC, Davies MCG, Luevano CH, Holzgrabe U, Huang R, Lagiakos HR, Leftheris K, Martin Y, Matos MJ, Dracka TLM. Empowering voices: inspiring women in medicinal chemistry [Editorial] [Internet]. Journal of Medicinal Chemistry. 2024 ; 67 4251-4258.[citado 2024 jul. 02 ] Available from: https://dx.doi.org/10.1021/acsmedchemlett.4c00097

  • Artigo de periodico

    Potential use of bixin beyond function as a natural colourant in food and cosmetics (2024)

    Takamoto, Rafael Teruiti de Oliveira; Hübner, Alexandra Almeida; Matuo, Míriam Cristina Sakuragui; Kikuchi, Irene Satiko

    Source: Natural Product Research. Unidade: FCF

    Subjects: CAROTENOIDES, URUCUM

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      TAKAMOTO, Rafael Teruiti de Oliveira et al. Potential use of bixin beyond function as a natural colourant in food and cosmetics. Natural Product Research, 2024Tradução . . Disponível em: https://dx.doi.org/10.1080/14786419.2024.2350634. Acesso em: 02 jul. 2024.

    • APA

      Takamoto, R. T. de O., Hübner, A. A., Matuo, M. C. S., & Kikuchi, I. S. (2024). Potential use of bixin beyond function as a natural colourant in food and cosmetics. Natural Product Research. doi:10.1080/14786419.2024.2350634

    • NLM

      Takamoto RT de O, Hübner AA, Matuo MCS, Kikuchi IS. Potential use of bixin beyond function as a natural colourant in food and cosmetics [Internet]. Natural Product Research. 2024 ;[citado 2024 jul. 02 ] Available from: https://dx.doi.org/10.1080/14786419.2024.2350634

    • Vancouver

      Takamoto RT de O, Hübner AA, Matuo MCS, Kikuchi IS. Potential use of bixin beyond function as a natural colourant in food and cosmetics [Internet]. Natural Product Research. 2024 ;[citado 2024 jul. 02 ] Available from: https://dx.doi.org/10.1080/14786419.2024.2350634

  • Artigo de periodico

    Enhancing analytical development in the pharmaceutical industry: a DoE-QSRR model for virtual method operable design region assessment (2024)

    Passarin, Paula Beatriz Silva ; Lourenço, Felipe Rebello

    Source: Journal of Pharmaceutical and Biomedical Analysis. Unidade: FCF

    Subjects: INDÚSTRIA FARMACÊUTICA, CROMATOGRAFIA LÍQUIDA

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      PASSARIN, Paula Beatriz Silva e LOURENÇO, Felipe Rebello. Enhancing analytical development in the pharmaceutical industry: a DoE-QSRR model for virtual method operable design region assessment. Journal of Pharmaceutical and Biomedical Analysis, v. 239, p. 1-12, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.jpba.2023.115907. Acesso em: 02 jul. 2024.

    • APA

      Passarin, P. B. S., & Lourenço, F. R. (2024). Enhancing analytical development in the pharmaceutical industry: a DoE-QSRR model for virtual method operable design region assessment. Journal of Pharmaceutical and Biomedical Analysis, 239, 1-12. doi:10.1016/j.jpba.2023.115907

    • NLM

      Passarin PBS, Lourenço FR. Enhancing analytical development in the pharmaceutical industry: a DoE-QSRR model for virtual method operable design region assessment [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2024 ; 239 1-12.[citado 2024 jul. 02 ] Available from: https://dx.doi.org/10.1016/j.jpba.2023.115907

    • Vancouver

      Passarin PBS, Lourenço FR. Enhancing analytical development in the pharmaceutical industry: a DoE-QSRR model for virtual method operable design region assessment [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2024 ; 239 1-12.[citado 2024 jul. 02 ] Available from: https://dx.doi.org/10.1016/j.jpba.2023.115907

  • Artigo de periodico

    The scenario of clays and clay minerals use in cosmetics/Dermocosmetics (2024)

    Sarruf, Fernanda Daud ; Contreras, Vecxi Judith Pereda; Martinez, Renata Miliani ; Velasco, Maria Valéria Robles ; Baby, André Rolim

    Source: Cosmetics. Unidade: FCF

    Subjects: ARGILAS, COSMÉTICOS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      SARRUF, Fernanda Daud et al. The scenario of clays and clay minerals use in cosmetics/Dermocosmetics. Cosmetics, v. 11, p. 1-21, 2024Tradução . . Disponível em: https://dx.doi.org/10.3390/cosmetics11010007. Acesso em: 02 jul. 2024.

    • APA

      Sarruf, F. D., Contreras, V. J. P., Martinez, R. M., Velasco, M. V. R., & Baby, A. R. (2024). The scenario of clays and clay minerals use in cosmetics/Dermocosmetics. Cosmetics, 11, 1-21. doi:10.3390/cosmetics11010007

    • NLM

      Sarruf FD, Contreras VJP, Martinez RM, Velasco MVR, Baby AR. The scenario of clays and clay minerals use in cosmetics/Dermocosmetics [Internet]. Cosmetics. 2024 ; 11 1-21.[citado 2024 jul. 02 ] Available from: https://dx.doi.org/10.3390/cosmetics11010007

    • Vancouver

      Sarruf FD, Contreras VJP, Martinez RM, Velasco MVR, Baby AR. The scenario of clays and clay minerals use in cosmetics/Dermocosmetics [Internet]. Cosmetics. 2024 ; 11 1-21.[citado 2024 jul. 02 ] Available from: https://dx.doi.org/10.3390/cosmetics11010007

  • Artigo de periodico

    Opening avenues for treatment of neurodegenerative disease using post-biotics: breakthroughs and bottlenecks in clinical translation (2024)

    Bashir, Bushra; Alam, Shahbaz; Khandale, Nikhil; Birla, Devendra; Vishwas, Sukriti ; Pandey, Narendra Kumar; Gupta, Gaurav; Paudel, Keshav Raj ; Dureja, Harish; Kumar, Puneet; Singh, Thakur Gurjeet; Kuppusamy, Gowthamarajan; Zacconi, Flavia C; Pinto, Terezinha de Jesus Andreoli ; Dhanasekaran, Muralikrishnan; Gulati, Monica; Dua, Kamal ; Singh, Sachin Kumar

    Source: Ageing Research Reviews. Unidade: FCF

    Subjects: DOENÇAS NEURODEGENERATIVAS, ENVELHECIMENTO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      BASHIR, Bushra et al. Opening avenues for treatment of neurodegenerative disease using post-biotics: breakthroughs and bottlenecks in clinical translation. Ageing Research Reviews, v. 95, p. 1-16 art. 102236, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.arr.2024.102236. Acesso em: 02 jul. 2024.

    • APA

      Bashir, B., Alam, S., Khandale, N., Birla, D., Vishwas, S., Pandey, N. K., et al. (2024). Opening avenues for treatment of neurodegenerative disease using post-biotics: breakthroughs and bottlenecks in clinical translation. Ageing Research Reviews, 95, 1-16 art. 102236. doi:10.1016/j.arr.2024.102236

    • NLM

      Bashir B, Alam S, Khandale N, Birla D, Vishwas S, Pandey NK, Gupta G, Paudel KR, Dureja H, Kumar P, Singh TG, Kuppusamy G, Zacconi FC, Pinto T de JA, Dhanasekaran M, Gulati M, Dua K, Singh SK. Opening avenues for treatment of neurodegenerative disease using post-biotics: breakthroughs and bottlenecks in clinical translation [Internet]. Ageing Research Reviews. 2024 ; 95 1-16 art. 102236.[citado 2024 jul. 02 ] Available from: https://dx.doi.org/10.1016/j.arr.2024.102236

    • Vancouver

      Bashir B, Alam S, Khandale N, Birla D, Vishwas S, Pandey NK, Gupta G, Paudel KR, Dureja H, Kumar P, Singh TG, Kuppusamy G, Zacconi FC, Pinto T de JA, Dhanasekaran M, Gulati M, Dua K, Singh SK. Opening avenues for treatment of neurodegenerative disease using post-biotics: breakthroughs and bottlenecks in clinical translation [Internet]. Ageing Research Reviews. 2024 ; 95 1-16 art. 102236.[citado 2024 jul. 02 ] Available from: https://dx.doi.org/10.1016/j.arr.2024.102236

  • Artigo de periodico

    HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents (2024)

    Waitman, Karoline de Barros ; Almeida, Larissa Costa de ; Primi, Marina Candido ; Carlos, Jorge Antonio Elias Godoy ; Ruiz, Claudia; Kronenberger, Thales ; Laufer, Stefan; Goettert, Marcia Ines; Poso, Antti ; Vassiliades, Sandra Valeria ; Souza, Vinicius Albuquerque Moreira de ; Toledo, Mônica Franco Zannini Junqueira ; Hassimotto, Neuza Mariko Aymoto ; Cameron, Michael D; Bannister, Thomas D; Lotufo, Leticia Veras Costa ; Machado Neto, João Agostinho ; Tavares, Maurício T.; Parise Filho, Roberto

    Source: European Journal of Medicinal Chemistry. Unidades: FCF, ICB

    Subjects: ANTINEOPLÁSICOS, HIBRIDIZAÇÃO, CÉLULAS CULTIVADAS DE TUMOR, PROTEÍNAS, PURINAS, CITOTOXINAS

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      WAITMAN, Karoline de Barros et al. HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents. European Journal of Medicinal Chemistry, v. 263, p. 1-18 art. 115935, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.ejmech.2023.115935. Acesso em: 02 jul. 2024.

    • APA

      Waitman, K. de B., Almeida, L. C. de, Primi, M. C., Carlos, J. A. E. G., Ruiz, C., Kronenberger, T., et al. (2024). HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents. European Journal of Medicinal Chemistry, 263, 1-18 art. 115935. doi:10.1016/j.ejmech.2023.115935

    • NLM

      Waitman K de B, Almeida LC de, Primi MC, Carlos JAEG, Ruiz C, Kronenberger T, Laufer S, Goettert MI, Poso A, Vassiliades SV, Souza VAM de, Toledo MFZJ, Hassimotto NMA, Cameron MD, Bannister TD, Lotufo LVC, Machado Neto JA, Tavares MT, Parise Filho R. HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents [Internet]. European Journal of Medicinal Chemistry. 2024 ; 263 1-18 art. 115935.[citado 2024 jul. 02 ] Available from: https://dx.doi.org/10.1016/j.ejmech.2023.115935

    • Vancouver

      Waitman K de B, Almeida LC de, Primi MC, Carlos JAEG, Ruiz C, Kronenberger T, Laufer S, Goettert MI, Poso A, Vassiliades SV, Souza VAM de, Toledo MFZJ, Hassimotto NMA, Cameron MD, Bannister TD, Lotufo LVC, Machado Neto JA, Tavares MT, Parise Filho R. HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents [Internet]. European Journal of Medicinal Chemistry. 2024 ; 263 1-18 art. 115935.[citado 2024 jul. 02 ] Available from: https://dx.doi.org/10.1016/j.ejmech.2023.115935

  • Artigo de periodico

    Recent advances in mitigating biofilms on medical devices (2024)

    Lirio, Adriana Cogo Malgueiro ; Ghisleni, Daniela Dal Molim ; Chellappan, Dinesh Kumar ; Dua, Kamal ; Pinto, Terezinha de Jesus Andreoli

    Source: ISAR Journal of Medical and Pharmaceutical Science. Unidade: FCF

    Subjects: BIOFILMES, VIRULÊNCIA

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      LIRIO, Adriana Cogo Malgueiro et al. Recent advances in mitigating biofilms on medical devices. ISAR Journal of Medical and Pharmaceutical Science, v. 2, p. 19-22, 2024Tradução . . Disponível em: https://dx.doi.org/10.5281/zenodo.10876918. Acesso em: 02 jul. 2024.

    • APA

      Lirio, A. C. M., Ghisleni, D. D. M., Chellappan, D. K., Dua, K., & Pinto, T. de J. A. (2024). Recent advances in mitigating biofilms on medical devices. ISAR Journal of Medical and Pharmaceutical Science, 2, 19-22. doi:10.5281/zenodo.10876918

    • NLM

      Lirio ACM, Ghisleni DDM, Chellappan DK, Dua K, Pinto T de JA. Recent advances in mitigating biofilms on medical devices [Internet]. ISAR Journal of Medical and Pharmaceutical Science. 2024 ; 2 19-22.[citado 2024 jul. 02 ] Available from: https://dx.doi.org/10.5281/zenodo.10876918

    • Vancouver

      Lirio ACM, Ghisleni DDM, Chellappan DK, Dua K, Pinto T de JA. Recent advances in mitigating biofilms on medical devices [Internet]. ISAR Journal of Medical and Pharmaceutical Science. 2024 ; 2 19-22.[citado 2024 jul. 02 ] Available from: https://dx.doi.org/10.5281/zenodo.10876918

  • Artigo de periodico

    In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors (2024)

    Yousef, Malaz ; O’Croinin, Conor; Le, Tyson S; Park, Chulhun ; Zuo, Jieyu; Bou-Chacra, Nadia Araci ; Davies, Neal M ; Löbenberg, Raimar

    Source: Pharmaceutics. Unidade: FCF

    Subjects: FARMACOCINÉTICA, FARMACODINÂMICA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      YOUSEF, Malaz et al. In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors. Pharmaceutics, v. 16, n. 6 p. 1-13 art. 768, 2024Tradução . . Disponível em: https://dx.doi.org/10.3390/pharmaceutics16060768. Acesso em: 02 jul. 2024.

    • APA

      Yousef, M., O’Croinin, C., Le, T. S., Park, C., Zuo, J., Bou-Chacra, N. A., et al. (2024). In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors. Pharmaceutics, 16( 6 p. 1-13 art. 768). doi:10.3390/pharmaceutics16060768

    • NLM

      Yousef M, O’Croinin C, Le TS, Park C, Zuo J, Bou-Chacra NA, Davies NM, Löbenberg R. In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors [Internet]. Pharmaceutics. 2024 ; 16( 6 p. 1-13 art. 768):[citado 2024 jul. 02 ] Available from: https://dx.doi.org/10.3390/pharmaceutics16060768

    • Vancouver

      Yousef M, O’Croinin C, Le TS, Park C, Zuo J, Bou-Chacra NA, Davies NM, Löbenberg R. In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors [Internet]. Pharmaceutics. 2024 ; 16( 6 p. 1-13 art. 768):[citado 2024 jul. 02 ] Available from: https://dx.doi.org/10.3390/pharmaceutics16060768

  • Artigo de periodico

    Assessing the utility of in silico tools in early drug development: The case of a pharmaceutically relevant formulation of the prodrug psilocybin (2024)

    Richter, Luca Maurice ; Al-Gousous, Jozef ; Araujo, Gabriel Lima Barros de ; Davies, Neal M ; Löbenberg, Raimar

    Source: Journal of Drug Delivery Science and Technology. Unidade: FCF

    Subjects: DEPRESSÃO, MEDICAMENTO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      RICHTER, Luca Maurice et al. Assessing the utility of in silico tools in early drug development: The case of a pharmaceutically relevant formulation of the prodrug psilocybin. Journal of Drug Delivery Science and Technology, v. 92, p. 1-14, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.jddst.2023.105305. Acesso em: 02 jul. 2024.

    • APA

      Richter, L. M., Al-Gousous, J., Araujo, G. L. B. de, Davies, N. M., & Löbenberg, R. (2024). Assessing the utility of in silico tools in early drug development: The case of a pharmaceutically relevant formulation of the prodrug psilocybin. Journal of Drug Delivery Science and Technology, 92, 1-14. doi:10.1016/j.jddst.2023.105305

    • NLM

      Richter LM, Al-Gousous J, Araujo GLB de, Davies NM, Löbenberg R. Assessing the utility of in silico tools in early drug development: The case of a pharmaceutically relevant formulation of the prodrug psilocybin [Internet]. Journal of Drug Delivery Science and Technology. 2024 ; 92 1-14.[citado 2024 jul. 02 ] Available from: https://dx.doi.org/10.1016/j.jddst.2023.105305

    • Vancouver

      Richter LM, Al-Gousous J, Araujo GLB de, Davies NM, Löbenberg R. Assessing the utility of in silico tools in early drug development: The case of a pharmaceutically relevant formulation of the prodrug psilocybin [Internet]. Journal of Drug Delivery Science and Technology. 2024 ; 92 1-14.[citado 2024 jul. 02 ] Available from: https://dx.doi.org/10.1016/j.jddst.2023.105305

  • Artigo de periodico

    How do physicochemical properties contribute to inhibitory activity of promising peptides against Zika Virus NS3 protease? (2024)

    Savino, Débora Feliciano; Silva, João Vitor da ; Santos, Soraya da Silva ; Lourenço, Felipe Rebello ; Giarolla, Jeanine

    Source: Journal of Molecular Modeling. Unidade: FCF

    Subjects: ZIKA VÍRUS, PEPTÍDEOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      SAVINO, Débora Feliciano et al. How do physicochemical properties contribute to inhibitory activity of promising peptides against Zika Virus NS3 protease?. Journal of Molecular Modeling, v. 30, n. 2, p. 1-19, 2024Tradução . . Disponível em: https://dx.doi.org/10.1007/s00894-024-05843-1. Acesso em: 02 jul. 2024.

    • APA

      Savino, D. F., Silva, J. V. da, Santos, S. da S., Lourenço, F. R., & Giarolla, J. (2024). How do physicochemical properties contribute to inhibitory activity of promising peptides against Zika Virus NS3 protease? Journal of Molecular Modeling, 30( 2), 1-19. doi:10.1007/s00894-024-05843-1

    • NLM

      Savino DF, Silva JV da, Santos S da S, Lourenço FR, Giarolla J. How do physicochemical properties contribute to inhibitory activity of promising peptides against Zika Virus NS3 protease? [Internet]. Journal of Molecular Modeling. 2024 ; 30( 2): 1-19.[citado 2024 jul. 02 ] Available from: https://dx.doi.org/10.1007/s00894-024-05843-1

    • Vancouver

      Savino DF, Silva JV da, Santos S da S, Lourenço FR, Giarolla J. How do physicochemical properties contribute to inhibitory activity of promising peptides against Zika Virus NS3 protease? [Internet]. Journal of Molecular Modeling. 2024 ; 30( 2): 1-19.[citado 2024 jul. 02 ] Available from: https://dx.doi.org/10.1007/s00894-024-05843-1

  • Monografia/livro

    Immunotherapy against lung cancer: emerging opportunities and challenges (2024)

    Bhatt, Shvetank ; Eri, Rajaraman; Goh, Bey Hing ; Paudel, Keshav Raj ; Pinto, Terezinha de Jesus Andreoli ; Dua, Kamal

    Unidade: FCF

    Subjects: IMUNOTERAPIA, NEOPLASIAS PULMONARES

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      BHATT, Shvetank et al. Immunotherapy against lung cancer: emerging opportunities and challenges. . Singapore: Springer. . Acesso em: 02 jul. 2024. , 2024

    • APA

      Bhatt, S., Eri, R., Goh, B. H., Paudel, K. R., Pinto, T. de J. A., & Dua, K. (2024). Immunotherapy against lung cancer: emerging opportunities and challenges. Singapore: Springer.

    • NLM

      Bhatt S, Eri R, Goh BH, Paudel KR, Pinto T de JA, Dua K. Immunotherapy against lung cancer: emerging opportunities and challenges. 2024 ;[citado 2024 jul. 02 ]

    • Vancouver

      Bhatt S, Eri R, Goh BH, Paudel KR, Pinto T de JA, Dua K. Immunotherapy against lung cancer: emerging opportunities and challenges. 2024 ;[citado 2024 jul. 02 ]

  • Artigo de periodico

    Effects of liquid and bar soaps on the skin of Brazilian Sewborns: a randomized controlled trial (2024)

    Ramos, Mily Constanza Moreno; Velasco, Maria Valéria Robles ; Bueno, Mariana; Veríssimo, Maria De La Ó Ramallo

    Source: Skin Pharmacology and Physiology. Unidades: FCF, EE

    Subjects: RECÉM-NASCIDO, PELE, HIGIENE

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      RAMOS, Mily Constanza Moreno et al. Effects of liquid and bar soaps on the skin of Brazilian Sewborns: a randomized controlled trial. Skin Pharmacology and Physiology, v. 36, n. 6, p. 267–277, 2024Tradução . . Disponível em: https://dx.doi.org/10.1159/000536066. Acesso em: 02 jul. 2024.

    • APA

      Ramos, M. C. M., Velasco, M. V. R., Bueno, M., & Veríssimo, M. D. L. Ó. R. (2024). Effects of liquid and bar soaps on the skin of Brazilian Sewborns: a randomized controlled trial. Skin Pharmacology and Physiology, 36( 6), 267–277. doi:10.1159/000536066

    • NLM

      Ramos MCM, Velasco MVR, Bueno M, Veríssimo MDLÓR. Effects of liquid and bar soaps on the skin of Brazilian Sewborns: a randomized controlled trial [Internet]. Skin Pharmacology and Physiology. 2024 ; 36( 6): 267–277.[citado 2024 jul. 02 ] Available from: https://dx.doi.org/10.1159/000536066

    • Vancouver

      Ramos MCM, Velasco MVR, Bueno M, Veríssimo MDLÓR. Effects of liquid and bar soaps on the skin of Brazilian Sewborns: a randomized controlled trial [Internet]. Skin Pharmacology and Physiology. 2024 ; 36( 6): 267–277.[citado 2024 jul. 02 ] Available from: https://dx.doi.org/10.1159/000536066

  • Artigo de periodico

    Risk of false conformity decisions due to measurement uncertainty of Active Pharmaceutical Ingredient: a multiparametric evaluation (2024)

    Amaral, Gustavo Kenji Toko Purcino do; Lourenço, Felipe Rebello

    Source: Brazilian Journal of Pharmaceutical Sciences. Unidade: FCF

    Subjects: MEDIÇÃO DE RISCO, MÉTODO DE MONTE CARLO, QUALIDADE DOS MEDICAMENTOS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      AMARAL, Gustavo Kenji Toko Purcino do e LOURENÇO, Felipe Rebello. Risk of false conformity decisions due to measurement uncertainty of Active Pharmaceutical Ingredient: a multiparametric evaluation. Brazilian Journal of Pharmaceutical Sciences, v. 60, p. 1-9, 2024Tradução . . Disponível em: https://dx.doi.org/10.1590/s2175-97902024e23565. Acesso em: 02 jul. 2024.

    • APA

      Amaral, G. K. T. P. do, & Lourenço, F. R. (2024). Risk of false conformity decisions due to measurement uncertainty of Active Pharmaceutical Ingredient: a multiparametric evaluation. Brazilian Journal of Pharmaceutical Sciences, 60, 1-9. doi:10.1590/s2175-97902024e23565

    • NLM

      Amaral GKTP do, Lourenço FR. Risk of false conformity decisions due to measurement uncertainty of Active Pharmaceutical Ingredient: a multiparametric evaluation [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2024 ; 60 1-9.[citado 2024 jul. 02 ] Available from: https://dx.doi.org/10.1590/s2175-97902024e23565

    • Vancouver

      Amaral GKTP do, Lourenço FR. Risk of false conformity decisions due to measurement uncertainty of Active Pharmaceutical Ingredient: a multiparametric evaluation [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2024 ; 60 1-9.[citado 2024 jul. 02 ] Available from: https://dx.doi.org/10.1590/s2175-97902024e23565

  • Artigo de periodico

    SETDB1 as a cancer target: challenges and perspectives in drug design (2024)

    Hassanie, Haifa ; Penteado, André Berndt ; Almeida, Larissa Costa de ; Calil, Raisa Ludmila; Emery, Flavio da Silva ; Lotufo, Leticia Veras Costa ; Trossini, Gustavo Henrique Goulart

    Source: RSC Medicinal Chemistry. Unidades: FCFRP, ICB, FCF

    Subjects: NEOPLASIAS, MEDICAMENTO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      HASSANIE, Haifa et al. SETDB1 as a cancer target: challenges and perspectives in drug design. RSC Medicinal Chemistry, v. 15, n. 5, p. 1424-1451, 2024Tradução . . Disponível em: https://dx.doi.org/10.1039/D3MD00366C. Acesso em: 02 jul. 2024.

    • APA

      Hassanie, H., Penteado, A. B., Almeida, L. C. de, Calil, R. L., Emery, F. da S., Lotufo, L. V. C., & Trossini, G. H. G. (2024). SETDB1 as a cancer target: challenges and perspectives in drug design. RSC Medicinal Chemistry, 15( 5), 1424-1451. doi:10.1039/D3MD00366C

    • NLM

      Hassanie H, Penteado AB, Almeida LC de, Calil RL, Emery F da S, Lotufo LVC, Trossini GHG. SETDB1 as a cancer target: challenges and perspectives in drug design [Internet]. RSC Medicinal Chemistry. 2024 ; 15( 5): 1424-1451.[citado 2024 jul. 02 ] Available from: https://dx.doi.org/10.1039/D3MD00366C

    • Vancouver

      Hassanie H, Penteado AB, Almeida LC de, Calil RL, Emery F da S, Lotufo LVC, Trossini GHG. SETDB1 as a cancer target: challenges and perspectives in drug design [Internet]. RSC Medicinal Chemistry. 2024 ; 15( 5): 1424-1451.[citado 2024 jul. 02 ] Available from: https://dx.doi.org/10.1039/D3MD00366C

  • Artigo de periodico

    Challenging the safety and efficacy of topically applied chlorogenic acid, apigenin, kaempferol, and naringenin by HET-CAM, HPLC-TBARS-EVSC, and laser Doppler flowmetry (2024)

    Ruscinc, Nadia ; Serafim, Ricardo Augusto Massarico; Almeida, Cíntia; Rosado, Catarina ; Baby, André Rolim

    Source: Fronters Chemistry. Unidade: FCF

    Subjects: POLIFENÓIS, COSMÉTICOS, ANTI-INFLAMATÓRIOS, ANTIOXIDANTES

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      RUSCINC, Nadia et al. Challenging the safety and efficacy of topically applied chlorogenic acid, apigenin, kaempferol, and naringenin by HET-CAM, HPLC-TBARS-EVSC, and laser Doppler flowmetry. Fronters Chemistry, v. 12, p. 1-11 art. 1400881, 2024Tradução . . Disponível em: https://dx.doi.org/10.3389/fchem.2024.1400881. Acesso em: 02 jul. 2024.

    • APA

      Ruscinc, N., Serafim, R. A. M., Almeida, C., Rosado, C., & Baby, A. R. (2024). Challenging the safety and efficacy of topically applied chlorogenic acid, apigenin, kaempferol, and naringenin by HET-CAM, HPLC-TBARS-EVSC, and laser Doppler flowmetry. Fronters Chemistry, 12, 1-11 art. 1400881. doi:10.3389/fchem.2024.1400881

    • NLM

      Ruscinc N, Serafim RAM, Almeida C, Rosado C, Baby AR. Challenging the safety and efficacy of topically applied chlorogenic acid, apigenin, kaempferol, and naringenin by HET-CAM, HPLC-TBARS-EVSC, and laser Doppler flowmetry [Internet]. Fronters Chemistry. 2024 ; 12 1-11 art. 1400881.[citado 2024 jul. 02 ] Available from: https://dx.doi.org/10.3389/fchem.2024.1400881.

    • Vancouver

      Ruscinc N, Serafim RAM, Almeida C, Rosado C, Baby AR. Challenging the safety and efficacy of topically applied chlorogenic acid, apigenin, kaempferol, and naringenin by HET-CAM, HPLC-TBARS-EVSC, and laser Doppler flowmetry [Internet]. Fronters Chemistry. 2024 ; 12 1-11 art. 1400881.[citado 2024 jul. 02 ] Available from: https://dx.doi.org/10.3389/fchem.2024.1400881.

  • Artigo de periodico

    Development and validation of a UV spectrophotometric method for biowaiver studies in pyrazinamide tablets (2024)

    Bobadilla, Vanessa Saldaña; Villanueva, Cintia P. Barreto; Gasco, Frizzi J. Ganoza; Chauca, Enma Perez; Aquiño, Olga E. Caballero; Rodriguez, Ana E. Mantilla; Plasencia, Pedro Marcelo Alva; Aurora-Prado, Maria Segunda

    Source: Journal of Pharmacy and Pharmacognosy Research. Unidade: FCF

    Subjects: ESPECTROFOTOMETRIA, BIOEQUIVALÊNCIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      BOBADILLA, Vanessa Saldaña et al. Development and validation of a UV spectrophotometric method for biowaiver studies in pyrazinamide tablets. Journal of Pharmacy and Pharmacognosy Research, v. 12, n. 3, p. 539-547, 2024Tradução . . Disponível em: https://dx.doi.org/10.56499/jppres23.1846_12.3.539. Acesso em: 02 jul. 2024.

    • APA

      Bobadilla, V. S., Villanueva, C. P. B., Gasco, F. J. G., Chauca, E. P., Aquiño, O. E. C., Rodriguez, A. E. M., et al. (2024). Development and validation of a UV spectrophotometric method for biowaiver studies in pyrazinamide tablets. Journal of Pharmacy and Pharmacognosy Research, 12( 3), 539-547. doi:10.56499/jppres23.1846_12.3.539

    • NLM

      Bobadilla VS, Villanueva CPB, Gasco FJG, Chauca EP, Aquiño OEC, Rodriguez AEM, Plasencia PMA, Aurora-Prado MS. Development and validation of a UV spectrophotometric method for biowaiver studies in pyrazinamide tablets [Internet]. Journal of Pharmacy and Pharmacognosy Research. 2024 ; 12( 3): 539-547.[citado 2024 jul. 02 ] Available from: https://dx.doi.org/10.56499/jppres23.1846_12.3.539

    • Vancouver

      Bobadilla VS, Villanueva CPB, Gasco FJG, Chauca EP, Aquiño OEC, Rodriguez AEM, Plasencia PMA, Aurora-Prado MS. Development and validation of a UV spectrophotometric method for biowaiver studies in pyrazinamide tablets [Internet]. Journal of Pharmacy and Pharmacognosy Research. 2024 ; 12( 3): 539-547.[citado 2024 jul. 02 ] Available from: https://dx.doi.org/10.56499/jppres23.1846_12.3.539

  • Artigo de periodico

    Measurement uncertainty for < 905 > Uniformity of Dosage Units tests using Monte Carlo and bootstrapping methods – Uncertainties arising from sampling and analytical steps (2024)

    Martins, Maisa Torres; Lourenço, Felipe Rebello

    Source: Journal of Pharmaceutical and Biomedical Analysis. Unidade: FCF

    Subjects: MEDICAMENTO, MÉTODO DE MONTE CARLO, MEDIÇÃO DE RISCO

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      MARTINS, Maisa Torres e LOURENÇO, Felipe Rebello. Measurement uncertainty for < 905 > Uniformity of Dosage Units tests using Monte Carlo and bootstrapping methods – Uncertainties arising from sampling and analytical steps. Journal of Pharmaceutical and Biomedical Analysis, v. 238, p. 1-8 art. 115857, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.jpba.2023.115857. Acesso em: 02 jul. 2024.

    • APA

      Martins, M. T., & Lourenço, F. R. (2024). Measurement uncertainty for < 905 > Uniformity of Dosage Units tests using Monte Carlo and bootstrapping methods – Uncertainties arising from sampling and analytical steps. Journal of Pharmaceutical and Biomedical Analysis, 238, 1-8 art. 115857. doi:10.1016/j.jpba.2023.115857

    • NLM

      Martins MT, Lourenço FR. Measurement uncertainty for < 905 > Uniformity of Dosage Units tests using Monte Carlo and bootstrapping methods – Uncertainties arising from sampling and analytical steps [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2024 ; 238 1-8 art. 115857.[citado 2024 jul. 02 ] Available from: https://dx.doi.org/10.1016/j.jpba.2023.115857

    • Vancouver

      Martins MT, Lourenço FR. Measurement uncertainty for < 905 > Uniformity of Dosage Units tests using Monte Carlo and bootstrapping methods – Uncertainties arising from sampling and analytical steps [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2024 ; 238 1-8 art. 115857.[citado 2024 jul. 02 ] Available from: https://dx.doi.org/10.1016/j.jpba.2023.115857

  • Artigo de periodico

    HTA criteria adopted in different models of public healthcare systems for orphan drugs: a scoping review (2024)

    Felippini, Arturo; Biglia, Luiza Vasconcelos; Lima, Tácio de Mendonça ; Aguiar, Patrícia Melo

    Source: Health Policy. Unidade: FCF

    Subjects: DOENÇAS RARAS, MEDICAMENTO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      FELIPPINI, Arturo et al. HTA criteria adopted in different models of public healthcare systems for orphan drugs: a scoping review. Health Policy, v. 144, p. 1-8 art. 105080, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.healthpol.2024.105080. Acesso em: 02 jul. 2024.

    • APA

      Felippini, A., Biglia, L. V., Lima, T. de M., & Aguiar, P. M. (2024). HTA criteria adopted in different models of public healthcare systems for orphan drugs: a scoping review. Health Policy, 144, 1-8 art. 105080. doi:10.1016/j.healthpol.2024.105080

    • NLM

      Felippini A, Biglia LV, Lima T de M, Aguiar PM. HTA criteria adopted in different models of public healthcare systems for orphan drugs: a scoping review [Internet]. Health Policy. 2024 ; 144 1-8 art. 105080.[citado 2024 jul. 02 ] Available from: https://dx.doi.org/10.1016/j.healthpol.2024.105080

    • Vancouver

      Felippini A, Biglia LV, Lima T de M, Aguiar PM. HTA criteria adopted in different models of public healthcare systems for orphan drugs: a scoping review [Internet]. Health Policy. 2024 ; 144 1-8 art. 105080.[citado 2024 jul. 02 ] Available from: https://dx.doi.org/10.1016/j.healthpol.2024.105080

  • Trabalho de evento-resumo

    Development of risk-management approach in additive manufacturing of orthopedic implants (2024)

    Lirio, Adriana Cogo Malgueiro ; Pinto, Terezinha de Jesus Andreoli

    Source: Proceedings. Conference titles: World Congress on Recent Advances in Nanotechnology/RAN. Unidade: FCF

    Subjects: MANUFATURA ADITIVA, ORTOPEDIA

    Acesso à fonteHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      LIRIO, Adriana Cogo Malgueiro e PINTO, Terezinha de Jesus Andreoli. Development of risk-management approach in additive manufacturing of orthopedic implants. 2024, Anais.. London: International Aset Inc., 2024. Disponível em: https://avestia.com/RAN2024_Proceedings/files/RAN24_Proceedings.pdf. Acesso em: 02 jul. 2024.

    • APA

      Lirio, A. C. M., & Pinto, T. de J. A. (2024). Development of risk-management approach in additive manufacturing of orthopedic implants. In Proceedings. London: International Aset Inc. Recuperado de https://avestia.com/RAN2024_Proceedings/files/RAN24_Proceedings.pdf

    • NLM

      Lirio ACM, Pinto T de JA. Development of risk-management approach in additive manufacturing of orthopedic implants [Internet]. Proceedings. 2024 ;[citado 2024 jul. 02 ] Available from: https://avestia.com/RAN2024_Proceedings/files/RAN24_Proceedings.pdf

    • Vancouver

      Lirio ACM, Pinto T de JA. Development of risk-management approach in additive manufacturing of orthopedic implants [Internet]. Proceedings. 2024 ;[citado 2024 jul. 02 ] Available from: https://avestia.com/RAN2024_Proceedings/files/RAN24_Proceedings.pdf

1 - 20 (5.040 records)

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024